BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Quattrocelli M, Zelikovich AS, Salamone IM, Fischer JA, McNally EM. Mechanisms and Clinical Applications of Glucocorticoid Steroids in Muscular Dystrophy. J Neuromuscul Dis 2021;8:39-52. [PMID: 33104035 DOI: 10.3233/JND-200556] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Farini A, Villa C, Tripodi L, Legato M, Torrente Y. Role of Immunoglobulins in Muscular Dystrophies and Inflammatory Myopathies. Front Immunol 2021;12:666879. [PMID: 34335568 DOI: 10.3389/fimmu.2021.666879] [Reference Citation Analysis]
2 Lopez C, Taivassalo T, Berru MG, Saavedra A, Rasmussen HC, Batra A, Arora H, Roetzheim AM, Walter GA, Vandenborne K, Forbes SC. Postcontractile blood oxygenation level-dependent (BOLD) response in Duchenne muscular dystrophy. J Appl Physiol (1985) 2021;131:83-94. [PMID: 34013753 DOI: 10.1152/japplphysiol.00634.2020] [Reference Citation Analysis]
3 Angelini G, Mura G, Messina G. Therapeutic approaches to preserve the musculature in Duchenne Muscular Dystrophy: The importance of the secondary therapies. Exp Cell Res 2022;410:112968. [PMID: 34883113 DOI: 10.1016/j.yexcr.2021.112968] [Reference Citation Analysis]
4 Ohlendieck K, Swandulla D. Complexity of skeletal muscle degeneration: multi-systems pathophysiology and organ crosstalk in dystrophinopathy. Pflugers Arch 2021;473:1813-39. [PMID: 34553265 DOI: 10.1007/s00424-021-02623-1] [Reference Citation Analysis]
5 Zelikovich AS, Joslin BC, Casey P, Mcnally EM, Ajroud-driss S. An Open Label Exploratory Clinical Trial Evaluating Safety and Tolerability of Once-Weekly Prednisone in Becker and Limb-Girdle Muscular Dystrophy. JND 2022. [DOI: 10.3233/jnd-210741] [Reference Citation Analysis]
6 Merckx C, De Paepe B. The Role of Taurine in Skeletal Muscle Functioning and Its Potential as a Supportive Treatment for Duchenne Muscular Dystrophy. Metabolites 2022;12:193. [DOI: 10.3390/metabo12020193] [Reference Citation Analysis]
7 Raffaghello L, Principi E, Baratto S, Panicucci C, Pintus S, Antonini F, Del Zotto G, Benzi A, Bruzzone S, Scudieri P, Minetti C, Gazzerro E, Bruno C. P2X7 Receptor Antagonist Reduces Fibrosis and Inflammation in a Mouse Model of Alpha-Sarcoglycan Muscular Dystrophy. Pharmaceuticals 2022;15:89. [DOI: 10.3390/ph15010089] [Reference Citation Analysis]
8 Yarlagadda S, Kulis C, Noakes PG, Smythe ML. Hematopoietic Prostaglandin D Synthase Inhibitor PK007 Decreases Muscle Necrosis in DMD mdx Model Mice. Life (Basel) 2021;11:994. [PMID: 34575143 DOI: 10.3390/life11090994] [Reference Citation Analysis]